Historical Aspects

Handbook of Meningococcal Disease: Infection Biology, Vaccination, Clinical Management

Volumn , Issue , 2006, Pages 1-13

  Cartwright, Keith ^a  

^a Brobury House   (United Kingdom)

Author keywords

Historical aspects; Meningococcal disease

Indexed keywords

EID: 84889484883     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527608508.ch1     Document Type: Chapter

References (53)

1. Jaeger H 1895, Zur aetiologie der meningitis cerebrospinalis epidemica, Zeitschr. Hyg. Infect. 19, 351-370.
2. Gates FL 1918, A report on antimeningitis vaccination and observations on agglutinins in the blood of chronic meningococcus carriers, J. Exp. Med. 28, 449-474.
3. Gordon MH, Murray EG 1915, Identification of the meningococcus, J. R. Army Med. Corps 25, 411-423.
4. Nicolle M, Debains E, Jouan C 1918, Etudes sur les méningococciques et les serums anti-méningococciques, Ann. Inst. Pasteur 32, 150-169.
5. Cartwright K 1995, Introduction and historical aspects, in Meningococcal Disease, ed. Cartwright K, John Wiley & Sons, Chichester, p. 1-19.
6. Willis T 1684, A description of an epidemical feaver... 1661, in Practice of Physics, Treatise VIII, T Dring, London, p. 46-54.
7. Vieusseux M 1806, Memoire sur la maladie qui a régné à Genève au printemps de 1805, J. Med. Chir. Pharmacol. 11, 163-182.
8. Danielson L, Mann E 1806, The history of a singular and very mortal disease, which lately made its appearance in Medfield, Med. Agric. Reg. 1, 65.
9. Hirsch A 1886, Epidemic cerebro-spinal meningitis, in Handbook of Geographical and Historical Pathology, vol III-Diseases of Organs and Parts (translated from the German by Creighton C), New Sydenham Society, London, p. 547-594.
10. Marchiafava E, Celli A 1884, Spra i micrococchi della meningite cerebrospinale epidemica, Gazz. Osped. 5, 59.
11. Weichselbaum A 1887, Ueber die aetiologie der akuten meningitis cerebro-spinalis epidemica, Fortschr. Med. 5, 573-583, 620-626.
12. Quincke HI 1893, Ueber meningitis serosa, Samml. Klin. Vort. 67, 655-694.
13. Voelcker AF 1894, Abstract of post mortem report, Middx Hosp. Rep. Med. Surg. Pathol. Reg. 1894, 278.
14. Heubner JOL 1896, Beobachtungen und versuche über den meningokokkus intracellularis (Weichselbaum-Jaeger), Jb. Kinderheilk. 43, 1-22.
15. Kiefer F 1896, Zur differentialdiagnose des erregers der epidemischen cerebrospinal-meningitis und der gonorrhoe, Berl. Klin. Woch. 33, 628-630.
16. Jochmann G 1906, Versuche zur serodiagnostik und serotherapie der epidemischen genickstarre, Dtsch Med. Wschr. 32, 788-793.
17. Flexner S, Jobling JW 1908, An analysis of four hundred cases of epidemic meningitis treated with the anti-meningitis serum, J. Exp. Med. 10, 690-733.
18. Netter A, Debré R 1911, La Méningite Cérébrospinale, Masson, Paris.
19. Waterhouse R 1911, A case of supra-renal apoplexy, Lancet 1911, 577-578.
20. Sophian A, Black J 1912, Prophylactic vaccination against epidemic meningitis, J. Am. Med. Assoc. 59, 527-532.
21. Greenwood M 1917, The outbreak of cerebrospinal fever at Salisbury in 1914-15, Proc. R. Soc. Med. 10, 44-60.
22. Glover JA 1920, Observations of the meningococcus carrier rate and their application to the prevention of cerebro-spinal fever, Spec. Rep. Ser. Med. Res. Council 50, 133-165.
23. Friderichsen C 1918, Nebennierenapoplexie bei kleinen kindern, Jb. Kinderheilk. 87, 109-125.
24. Rolleston H 1919, Lumleian lectures on cerebro-spinal fever, Lecture 1, Lancet 1919, 541-549.
25. Fleming A 1929, On the antibacterial action of cultures of a penicillium with special reference to their use in the isolation of B. influenzae, Br. J. Exp. Pathol. 10, 226-236.
26. Scherp H, Rake G 1935, Studies on meningococcus infection, VIII, The type I specific substance, J. Exp. Med. 61, 753-769.
27. Schwentker FF 1937, Treatment of meningococcic meningitis with sulfanilamide, J. Pediatr. 11, 874-880.
28. Banks HS 1939, Chemotherapy of meningococcal meningitis, A review of 147 consecutive cases, Lancet 1939, 921-927.
29. Beeson PB, Westerman E 1943, Cerebrospinal fever, Analysis of 3,575 case reports, with special reference to sulphonamide therapy, Br. Med. J. 1, 497-500.
30. Fairbrother RW 1940, Cerebrospinal meningitis, The use of sulphonamide derivatives in prophylaxis, Br. Med. J. 2, 859-862.
31. Branham SE 1956, Milestones in the history of the meningococcus, Can. J. Microbiol. 2, 175-188.
32. Lapeysonnie L 1963, La méningite cérébro-spinale en Afrique, Bull. WHO 28[suppl], 3-114.
33. Millar JW, Siess EE, Feldman HA, et al. 1963, In vivo and in vitro resistance to sulfadiazine in strains of Neisseria meningitidis, J. Am. Med. Assoc. 186, 139-141.
34. Hollis DG, Wiggins GL, Weaver RE 1969, Neisseria lactamicus sp. n., a lactose-fermenting species resembling Neisseria meningitidis, Appl. Microbiol. 17, 71-77.
35. Goldschneider I, Gotschlich EC, Artenstein MS 1969, Human immunity to the meningococcus, I, The role of humoral antibodies, J. Exp. Med. 129, 1307-1326.
36. Goldschneider I, Gotschlich EC, Artenstein MS 1969, Human immunity to the meningococcus, II, Development of natural immunity, J. Exp. Med. 129, 1327-1348.
37. Gotschlich EC, Teh Yung Liu, Artenstein MS 1969, Human immunity to the meningococcus, III, Preparation and immunochemical properties of the group A, group B and group C meningococcal polysaccharides, J. Exp. Med. 129, 1349-1365.
38. Gotschlich EC, Goldschneider I, Artenstein MS 1969, Human immunity to the meningococcus, IV, Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers, J. Exp. Med. 129, 1367-1384.
39. Goldschneider I, Gotschlich EC, Artenstein MS 1969, Human immunity to the meningococcus, V, the effect of immunization with meningococcal group C polysaccharide on the carrier state, J. Exp. Med. 129, 1385-1395.
40. DeVoe IW 1982, The meningococcus and mechanisms of pathogenicity, Microb. Rev. 46, 162-190.
41. Olyhoek T, Crowe BA, Achtman M 1987, Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983, Rev. Infect. Dis. 9, 665-692.
42. Botha P 1988, Penicillin-resistant Neisseria meningitidis in Southern Africa, Lancet 1988, 54.
43. Sierra GVG, Campa HC, Varcacel NM, et al. 1991, Vaccine against serogroup B Neisseria meningitidis, Protection trial and mass vaccination results in Cuba, Natl Inst. Public Health Ann. 14, 195-210.
44. Kristiansen B-E, Ask E, Jenkins A, et al. 1991, Rapid diagnosis of meningococcal meningitis by polymerase chain reaction, Lancet 337, 1568-1569.
45. Nadel S, Newport MJ, Booy R, Levin M 1996, Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease, J. Infect. Dis. 174, 878-880.
46. Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. 1997, Genetic influence on cytokine production and fatal meningococcal disease, Lancet 349, 170-173.
47. Maiden MCJ, et al. 1998, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc. Natl Acad. Sci. USA 1998, 3140-3145.
48. Booy R, Habibi P, Nadel S, et al. 2001, Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery, Arch. Dis. Child 85, 386-390.
49. Miller E, Salisbury D, Ramsay M 2001, Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story, Vaccine 20[suppl], S58-S67.
50. Campagne G, Garba A, Fabre P, et al. 2000, Safety and immunogenicity of three doses of a Neisseria meningitidis A+C diphtheria conjugate vaccine in infants from Niger, Pediatr. Infect. Dis. J. 19, 144-150.
51. Taha MK, Achtman M, Alonso JM, et al. 2000, Serogroup W135 meningococcal disease in Hajj pilgrims, Lancet 356, 2159.
52. Tettelin H, Saunders NJ, Heidelberg J, et al. 2000, Complete genome sequence of Neisseria meningitidis serogroup B strain MC58, Science 287, 1809-1815.
53. Pizza M, Scarlato V, Masignani V, et al. 2000, Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing, Science 287, 1816-1820.